Danno K, Kume M, Ohta M, Utani A, Ohno S, Kobashi Y
J Dermatol. 1989 Oct;16(5):392-6. doi: 10.1111/j.1346-8138.1989.tb01287.x.
A 40-year-old man developed a generalized erythematous rash, fever, and systemic lymphadenopathy after treatment for two months with anticonvulsants including phenytoin. Laboratory examinations revealed increased white blood cell counts with eosinophilia, abnormal liver function, and increased gammaglobulin levels. A lymphocyte stimulation test showed a significant stimulation index for phenytoin. Skin biopsy findings were nonspecific cellular infiltrates in the upper dermis whereas in lymph nodes the normal architecture was replaced by massive cellular infiltrates consisting largely of lymphocytes, immunoblasts, and eosinophils suggesting a pattern of phenytoin lymphadenopathy. No malignant changes were noted. Phenytoin was discontinued and after a two-month treatment with oral corticosteroids, all manifestations had nearly subsided. However, the patient should be carefully followed up since phenytoin occasionally induces lymphoproliferative states including malignant lymphoma even after cessation of the medication.
一名40岁男性在使用包括苯妥英钠在内的抗惊厥药物治疗两个月后,出现了全身性红斑皮疹、发热和全身淋巴结病。实验室检查显示白细胞计数增加伴嗜酸性粒细胞增多、肝功能异常以及γ球蛋白水平升高。淋巴细胞刺激试验显示苯妥英钠的刺激指数显著。皮肤活检结果显示真皮上层有非特异性细胞浸润,而在淋巴结中,正常结构被大量主要由淋巴细胞、免疫母细胞和嗜酸性粒细胞组成的细胞浸润所取代,提示为苯妥英钠淋巴结病模式。未发现恶性改变。停用苯妥英钠,经口服皮质类固醇治疗两个月后,所有症状几乎消退。然而,该患者应密切随访,因为即使停药后,苯妥英钠偶尔也会诱发包括恶性淋巴瘤在内的淋巴增殖性疾病。